FDA Clears Qvin Test that Uses Menstrual Blood
The clearance makes it possible for women who live with diabetes to receive monitoring of A1c, using laboratory tests performed on the Q-Pad.
Read MorePosted by Andy Lundin | Jan 8, 2024 | Diabetes & Metabolic Diseases, Womens Health |
The clearance makes it possible for women who live with diabetes to receive monitoring of A1c, using laboratory tests performed on the Q-Pad.
Read MorePosted by Andy Lundin | Jan 2, 2024 | Cardiovascular, Diabetes & Metabolic Diseases |
A two-step screening protocol can effectively identify which patients with Type 2 diabetes need medication to prevent heart failure.
Read MorePosted by Andy Lundin | Dec 18, 2023 | Diagnostic Technologies |
A study detailed an AI-driven advance in biotechnology that bolsters disease detection, drug development, and environmental monitoring.
Read MorePosted by Andy Lundin | Nov 29, 2023 | Diabetes & Metabolic Diseases |
Researchers developed a device that detects glucose and adenosine monophosphate (AMP) biomarkers in saliva with high sensitivity.
Read MorePosted by Chris Wolski | Nov 24, 2023 | Tuberculosis |
Though without a standard TB diagnosis, guidelines recommend the use of either the TST or IGRAs to test for latent tuberculosis infections.
Read More